
Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ
Fin d'année 31 Décembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 1.973 | 14.838 | 45.672 | -0.209 | 4.296 | -3.239 | 6.73 | -0.466 |
Return on Equity (%) | 3.389 | 29.837 | 94.764 | -0.404 | 7.466 | -4.703 | 8.034 | -0.527 |
Return on Invested Capital (%) | 13.091 | 27.972 | -7.776 | 4.95 | 11.952 | 0.029 | 6.842 | 32.821 |
Operating Margin (%) | 48.639 | 88.13 | 692.027 | 9.056 | 24.149 | 19.267 | 48.979 | 3.324 |
Net Profit Margin (%) | 8.899 | 56.997 | 523.189 | -1.601 | 20.618 | -17 | 39.717 | -2.412 |
Book Value Per Share | 3.107 | 10.739 | 26.242 | -5.376 | 4.7 | 8.21 | 13.228 | 24.268 |
Earnings Per Share | 0.594 | 6.902 | 37.407 | -0.186 | 3.408 | -1.968 | 2.991 | -0.213 |
Cash Per Share | 0.975 | 5.642 | 4.253 | 2.961 | 1.164 | 2.655 | 1.316 | 3.827 |
Working Capital Per Share | -0.087 | 37.961 | 65.782 | 24.903 | 25.233 | 9.722 | 12.655 | 15.583 |
Operating Profit Per Share | 6.437 | 11.847 | 6.565 | 9.813 | 15.295 | 8.685 | 7.093 | 8.381 |
EBIT Per Share | 2.706 | 8.347 | 47.354 | -0.655 | 2.821 | 2.124 | 3.651 | 0.133 |
EBITDA Per Share | 2.706 | 8.347 | 47.354 | -0.655 | 2.821 | 2.124 | 3.651 | 0.133 |
Free Cash Flow Per Share | 0.104 | 6.622 | 34.959 | -1.62 | 0.885 | -3.155 | 3.985 | -1.983 |
Fin d'année 31 Décembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 21,15M | 20,77M | 16,82M | 16,08M | 16,77M | 16,95M | N/A | N/A |
Fin d'année 31 Décembre 2024 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 | Déc 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | 126.824 | N/A | N/A | N/A | 366.673 | N/A | N/A | N/A |
Net Profit Margin (%) | 95.384 | N/A | N/A | N/A | 278.065 | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 2,05B |
Ratio cours/bénéfice | -510,12 |
Ratio prix/ventes | 12,31 |
Ratio prix/liquidités | 28,45 |
Ratio prix/valeur comptable | 2,48 |
Rendement de dividende | - |
Actions en circulation | 19,26M |
Volume moyen (1 semaine) | 124,47k |
Volume moyen (1 mois) | 133k |
Variation sur 52 semaines | 32,19% |
Plus haut sur 52 semaines | 129,90 |
Plus bas sur 52 semaines | 67,72 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales